Acadian Asset Management LLC Bicycle Therapeutics PLC Transaction History

Acadian Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$12.95 - $46.99 $271,302 - $984,440	20,950 Added 58.26%	56,909 $954,000
Q1 2022 May 12, 2022	SELL	$40.12 - $59.5 $5.72 Million - $8.48 Million	-142,580 Reduced 79.86%	35,959 $1.58 Million
Q4 2021 Feb 10, 2022	BUY	$41.7 - $61.14 $6.56 Million - $9.62 Million	157,365 Added 743.2%	178,539 $10.9 Million
Q3 2021 Nov 12, 2021	BUY	$27.95 - $44.24 $341,576 - $540,657	12,221 Added 136.5%	21,174 $878,000
Q2 2021 Aug 11, 2021	SELL	$27.0 - $32.28 $796,689 - $952,485	-29,507 Reduced 76.72%	8,953 $272,000
Q1 2021 May 11, 2021	BUY	$19.12 - $30.25 $516,794 - $817,627	27,029 Added 236.45%	38,460 $1.15 Million
Q4 2020 Feb 11, 2021	BUY	$17.95 - $21.36 $205,186 - $244,166	11,431 New	11,431 $205,000

111

40.8M

39.6K

24.6K

Ticker BCYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,676,100
Market Cap $433M
Description
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.